{"drugs":["CVS Glucose","Dex4","Dextrose","Enfamil Glucose","Glutol","Glutose","Insta-Glucose","Similac Glucose"],"mono":{"0":{"id":"174350-s-0","title":"Generic Names","mono":"Dextrose"},"1":{"id":"174350-s-1","title":"Dosing and Indications","sub":{"0":{"id":"174350-s-1-4","title":"Adult Dosing","mono":"<ul><li><b>Glucose tolerance test:<\/b> Diabetes mellitus (diagnosis): 75 g anhydrous glucose (dextrose) dissolved in water ORALLY, as one-time dose for oral glucose tolerance test<\/li><li><b>Glucose tolerance test:<\/b> Gestational diabetes mellitus (diagnosis), one-step approach: 100 g anhydrous glucose (dextrose) dissolved in water ORALLY, as one-time dose for oral glucose tolerance test<\/li><li><b>Glucose tolerance test:<\/b> Gestational diabetes mellitus (diagnosis), two-step approach: 50 g anhydrous glucose (dextrose) dissolved in water ORALLY as one-time dose for glucose challenge test, then perform the 100-g oral glucose tolerance test on those who exceeded the threshold value on the glucose challenge test<\/li><li><b>Intravenous feeding of patient:<\/b> IV dose is dependent upon the age, weight and clinical condition of the patient<\/li><\/ul>"},"1":{"id":"174350-s-1-5","title":"Pediatric Dosing","mono":"<b>Intravenous feeding of patient:<\/b> IV dose is dependent upon the age, weight and clinical condition of the patient; particular caution in pediatric patients, particularly neonates and low birth weight infants "},"3":{"id":"174350-s-1-7","title":"Indications","mono":"<b>FDA-Labeled Indications<\/b><ul><li>Hypoglycemia<\/li><li>Intravenous feeding of patient<\/li><\/ul><b>Non-FDA Labeled Indications<\/b><ul><li>Deficiency of anterior cruciate ligament - Knee pain<\/li><li>Glucose tolerance test<\/li><li>Insulinoma<\/li><li>Oral rehydration therapy<\/li><li>Septic shock; Adjunct<\/li><\/ul>"}}},"3":{"id":"174350-s-3","title":"Contraindications\/Warnings","sub":[{"id":"174350-s-3-9","title":"Contraindications","mono":"simultaneous administration with blood through same infusion set; avoid due to possibility for pseudoagglutination of red cells (IV) <br\/>"},{"id":"174350-s-3-10","title":"Precautions","mono":"<ul><li>diabetes mellitus, subclinical or overt; use with caution<\/li><li>potassium-free solution, excessive administration; may result in significant hypokalemia (IV)<\/li><li>fluid and\/or solute overloading may occur, resulting in dilution of serum electrolyte concentrations, overhydration, congested states of pulmonary edema (IV)<\/li><li>pediatric patients, particularly neonates and low birth weight infants; increased risk of hyperglycemia or hypoglycemia; excessive or rapid infusion rate in very low birth weight infants may result in increased serum osmolarity and possible intracerebral hemorrhage (IV)<\/li><\/ul>"},{"id":"174350-s-3-11","title":"Pregnancy Category","mono":"C (FDA)<br\/>"},{"id":"174350-s-3-12","title":"Breast Feeding","mono":"Micromedex: Infant risk cannot be ruled out.<br\/>"}]},"5":{"id":"174350-s-5","title":"Adverse Effects","mono":"<b>Common<\/b><br\/><b>Endocrine metabolic:<\/b>Hyperglycemia<br\/><b>Serious<\/b><ul><li><b>Dermatologic:<\/b>Injection site extravasation<\/li><li><b>Endocrine metabolic:<\/b>Hyperosmolarity, Hypervolemia<\/li><li><b>Neurologic:<\/b>Cerebral hemorrhage, Cerebral ischemia<\/li><li><b>Respiratory:<\/b>Pulmonary edema<\/li><\/ul>"},"6":{"id":"174350-s-6","title":"Drug Name Info","sub":{"0":{"id":"174350-s-6-17","title":"US Trade Names","mono":"<ul><li>Insta-Glucose<\/li><li>Dex4<\/li><li>Enfamil Glucose<\/li><li>Glutol<\/li><li>Glutose<\/li><li>Similac Glucose<\/li><li>CVS Glucose<\/li><\/ul>"},"2":{"id":"174350-s-6-19","title":"Class","mono":"<ul><li>Glucose Regulation, Antihypoglycemic<\/li><li>Nutritive Agent<\/li><li>Osmotherapy Agent<\/li><li>Parenteral Solution<\/li><\/ul>"},"3":{"id":"174350-s-6-20","title":"Regulatory Status","mono":"RX\/OTC<br\/>"},"4":{"id":"174350-s-6-21","title":"Generic Availability","mono":"Yes<br\/>"}}},"7":{"id":"174350-s-7","title":"Mechanism Of Action","mono":"Dextrose solution provides a source of water and carbohydrate (340 kcal\/L). The simple carbohydrate may minimize liver glycogen depletion and provide a protein-sparing action.<br\/>"},"10":{"id":"174350-s-10","title":"Monitoring","mono":"<ul><li>adequate hydration and electrolyte balance are indicative of efficacy<\/li><li>changes in fluid balance, electrolyte concentrations, and acid-base balance; during prolonged parenteral therapy or when clinically warranted<\/li><li>blood and urine glucose<\/li><\/ul>"},"11":{"id":"174350-s-11","title":"How Supplied","mono":"<ul><li><b>Generic<\/b><br\/><ul><li>Intravenous Solution: 2.5 %, 5 %, 10 %, 20 %, 25 %, 30 %, 40 %, 50 %, 70 %<\/li><li>Oral Gel\/Jelly: 15 GM<\/li><li>Oral Tablet: 4 GM<\/li><li>Oral Tablet, Chewable: 4 GM, 5 GM<\/li><\/ul><\/li><li><b>Assorted Fruit Glucose<\/b><br\/>Oral Tablet: 4 GM<br\/><\/li><li><b>Dex4 Glucose<\/b><br\/>Oral Gel\/Jelly: 15 GM<br\/><\/li><li><b>Dex4<\/b><br\/><ul><li>Oral Gel\/Jelly: 15 GM<\/li><li>Oral Solution: 15 GM<\/li><li>Oral Tablet, Chewable: 1 GM, 4 GM<\/li><\/ul><\/li><li><b>Discount Drug Mart Glucose<\/b><br\/>Oral Tablet, Chewable: 4 GM<br\/><\/li><li><b>Glucose Tablets<\/b><br\/>Oral Tablet, Chewable: 4 GM<br\/><\/li><li><b>Glutol<\/b><br\/>Oral Solution: 100 GM\/180 ML<br\/><\/li><li><b>Glutose 15<\/b><br\/>Oral Gel\/Jelly: 15 GM, 40 %<br\/><\/li><li><b>Glutose 45<\/b><br\/>Oral Gel\/Jelly: 40 %<br\/><\/li><li><b>Glutose<\/b><br\/><ul><li>Oral Gel\/Jelly: 40 %<\/li><li>Oral Tablet, Chewable: 5 GM<\/li><\/ul><\/li><li><b>Good Neighbor Pharmacy Glucose<\/b><br\/><ul><li>Oral Gel\/Jelly: 15 GM<\/li><li>Oral Tablet: 4 GM<\/li><\/ul><\/li><li><b>Grape Glucose<\/b><br\/>Oral Tablet: 4 GM<br\/><\/li><li><b>Insta-Glucose<\/b><br\/>Oral Gel\/Jelly: 40 %<br\/><\/li><li><b>Rite Aid Glucose<\/b><br\/>Oral Tablet: 4 GM<br\/><\/li><li><b>Trueplus Glucose<\/b><br\/>Oral Gel\/Jelly: 15 GM<br\/><\/li><li><b>UltraTrak PRO Control<\/b><br\/>  Solution: 0.03-0.3 %<br\/><\/li><li><b>Up &amp; Up Glucose<\/b><br\/>Oral Tablet: 4 GM<br\/><\/li><\/ul>"}}}